Pharmaron Beijing Co., Ltd. Class A · SZSE:300759

Pharmaron Beijing Co., Ltd. Class A — Pharmaron — Corporate Update (November 2021)

8 slides from Pharmaron Beijing Co., Ltd. Class A's corporate update, Nov 9, 2021

  1. Slide 1: CMC (Small Molecule CDMO) Services Facilities

    CMC （ Small Molecule CDMO ） Services Facilities

  2. Slide 2: Manufacturing Capacity Summary

    1 Manufacturing Capacity Summary

  3. Slide 3: Facilities – Geographic Location

    Facilities – Geographic Location Beijing Headquarters (China)  Process – GMP API (OEL 5 µg/m3)  OSD Formulation – GMP DP  HiPo GMP API (OEL 0.1 µg/m3)  Clinical Phase l/ll Hoddesdon (UK)  GMP API (OEL 5 µg/m3) Tianjin (China)  Clinical Phase l/ll  Intermediates  GMP API (OEL 5 µg/m3)  Clini

  4. Slide 4: API Development Platform

    API Development Platform Process R&D Material Sciences Process Development Polymorphism Studies • Route exploration and • Salt and polymorph fit-for-purpose R&D screening • Commercial process R&D for • Solid state late stage APIs characterization Process Safety Crystal Engineering Process Engineerin

  5. Slide 5: Pharmaron Manufacturing Capability

    Pharmaron Manufacturing Capability IND-Enabling Phase I & II Phase III Commercial Beijing GMP Kilo Lab GMP intermediates, API Ningbo GMP Pilot Plant GMP intermediates, API Hoddesdon UK GMP intermediates, API GMP intermediates, API Tianjin Manufacturing Non GMP Starting Material, Intermediates Site G

  6. Slide 6: Manufacturing Capacity Summary

    Manufacturing Capacity Summary Beijing Ningbo Hoddesdon Shaoxing Tianjin Site GMP Kilo Lab Site Site Site Reactor Sizes 20 - 300 L 63 - 8,000 L 20 - 500 L 20 - 1000 L 300-12,500 L Total Capacity 2,430 L 175,863 L 22,900 L 4,580 L 634,800L Cryogenic Y Y Y Y Y Hydrogenation N Y Y Y Y Non-GMP Y Y Y Y Y

  7. Slide 7: Shaoxing Facility

    Mi gins 'G A aaah 2 Shaoxing Facility

  8. Slide 8: Shaoxing Facility

    Shaoxing Facility  Pharmaron Shaoxing located in a state-level economic and technological development zone in Shangyu (Shaoxing) with total land area of 250 mu (Chinese acres)  Phase I construction started from August 2019  First production campaign will be launched in 2021Q4

Pharmaron — Corporate Update (November 2021) on 6ix